...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Good post SanFran

Why did SF post get deleted, there was alot of Sacasim built into that post but nothing to extrordinary,...   strange,  i get this spidey sense that we are close to hearing soemthing from Zenith ,  How long can Zenith go before those 2.4million payble  and $800,000 per month expenses are called uopn to be paid,   seems we ar running on fumes,   maybe just maybe ... nAh  i have been fooled too many times  

Share
New Message
Please login to post a reply